Litcius/Paper detail

Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status

Takaaki Konuma, Satoshi Yamasaki, Ken Ishiyama, Shohei Mizuno, Hiromi Hayashi, Naoyuki Uchida, Masashi Shimabukuro, Masatsugu Tanaka, Takuro Kuriyama, Makoto Onizuka, Kazuya Ishiwata, Masashi Sawa, Takashi Tanaka, Hiroyuki Ohigashi, Shin‐ichiro Fujiwara, Ken‐ichi Matsuoka, Shuichi Ota, Tetsuya Nishida, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Hideki Nakasone, Masamitsu Yanada

2023Transplantation and Cellular Therapy19 citationsDOI

Topics & Concepts

Hazard ratioMedicineMyeloid leukemiaInternal medicineConfidence intervalAlleleTransplantationGastroenterologyHematopoietic stem cell transplantationLeukemiaCord bloodSurgeryImmunologyBiologyGeneticsGeneHematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia research
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status | Litcius